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As countries approach tuberculosis (TB) elimination goals, disease is expected to become 
increasingly concentrated amongst vulnerable individuals, posing both challenges and opportunities 
for improving interventions to achieve elimination. This issue of IJTLD sees the launch of a State of 
the Art Series entitled “Tuberculosis in Low Burden Countries”. The series will explore pre-elimination 
challenges faced by low TB-burden countries and covers TB epidemiology, prevention and control, 
focussing on population groups at the highest risk of infection and disease. 
 
During the 20th and 21st centuries, dramatic progress has been made in TB control in what are now 
low-burden countries (those with <10 incident cases/100,000/year [1]). In England, the TB notification 
and mortality rates were estimated at 215 and 181 per 100,000, respectively, in 1901, versus 12 and 
0.7 per 100,000 in 2000 [2]. Although TB showed some resurgence during the 2000s, incidence is 
again declining with the most recent data (2015) showing a notification rate in the United Kingdom of 
10.5 per 100,000 [3]. These reductions in morbidity and mortality in the UK, which have been 
observed in other low-burden settings, have been attributed to multiple interventions and societal 
changes, including improvements in diagnosis, improved effectiveness and availability of treatments, 
provision of BCG vaccination, social reforms and improved living conditions [4]. 
 
Despite these achievements, TB control remains a challenge due to both the biology of the infection 
and changes in the host population. The ability of Mycobacterium tuberculosis to establish latency, 
remaining viable within the lung without causing symptoms but able to subsequently reactivate and 
cause disease, means that actions targeted solely at treating active disease are unlikely to eliminate 
the disease. Due to increases in international travel and migration, TB notifications in low-burden 
countries increasingly reflect infections acquired abroad, e.g. approximately two thirds of TB cases 
notified in the USA in 2016 were born outside the country [5]. Migrants constitute a heterogeneous 
group, but may face particular barriers to diagnosis and treatment, including difficulties accessing 
healthcare or fear of health or immigration authorities. These vulnerabilities may be shared by other 
groups, such as homeless people, who also face a disproportionately high risk of TB and poorer 
health access due to financial, administrative or social barriers. Interventions to improve prevention, 
diagnosis and treatment in these groups will be critical in controlling TB in low-burden countries. 
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Co-morbidities also influence TB risk. The importance of HIV is well-recognised, and recently 
attention towards non-communicable conditions such as diabetes and immunosuppressive treatment 
has increased. Understanding how such conditions influence TB infection, disease and outcomes is 
increasingly important as life expectancies rise and lifestyles change, with associated increases in the 
prevalence of communicable and non-communicable chronic conditions. 
 
These aspects of the changing landscape of TB epidemiology in low-burden countries will be explored 
in this State of the Art Series. The papers will describe challenges, and solutions, to TB control in 
countries currently approaching elimination, providing an overview relevant to these countries now 
and to inform future strategies in countries currently experiencing a high burden of TB. 
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